Member of Technical Staff, AI
Pathos
Summary
You will play a major role in advancing the foundation model and building the agentic systems behind Foundry, the AI platform that informs every drug decision at Pathos, and make them continually improve over time from real-world feedback. You will own how we train and adapt frontier open-weight models specifically for drug development.
Job description
About the role
You will play a major role in advancing the foundation model and building the agentic systems behind Foundry, the AI platform that informs every drug decision at Pathos, and make them continually improve over time from real-world feedback. You will own how we train and adapt frontier open-weight models specifically for drug development.
You will leverage 200+ petabytes of multimodal, multi-scale oncology data spanning over 8 million patient records linked to longitudinal outcomes, alongside live data streams from clinical trial sites. Supported by a dedicated large-scale GPU cluster and our internal wet lab for experimental validation, your models will directly inform design and execution of clinical trials.
What You'll Build
- Advance mid- and post-training of our oncology foundation model across SFT and RL, including reward design and verifiers for scientific and clinical tasks whose correctness is hard to check automatically.
- Run and debug training at scale, addressing instability, divergence and reward hacking.
- Build the harness for scientific and clinical workflows: memory, context management, orchestration and tools, plus methods that optimize the harness automatically and evolve it together with the underlying model.
- Design evaluations for open-ended, long-horizon scientific, clinical and operational tasks, calibrate them against expert judgment, investigate where they fail, and use them to decide what ships.
- Build pipelines that generate, filter and curate training and evaluation data, with safeguards for quality, provenance and contamination.
- Turn expert feedback, wet-lab results and real-time signals from clinical trial sites into improvements to models, harness and evaluations, so the platform learns from experience with very high sample efficiency.
- Work directly with oncologists, biologists and the clinical team to translate drug development needs into tractable ML problems, and publish in top ML and scientific venues.
Who You Are
We're looking for researchers and engineers who have gotten models or agents working at scale, care as much about the drugs as about the models, and want their work to reach patients. You take ambiguous problems through experiments to results people can use. We're hiring across levels, from exceptional early-career talent to experienced researchers.
Must-haves
- Deep, hands-on expertise in at least one of the following, which we value equally: Mid- or post-training at scale, such as SFT, RL, reward modeling or preference optimization, with direct ownership of training runs and results.
- Evaluation, data and agent harness design, such as evaluation and feedback design for scientific, clinical and operational tasks, synthetic data pipelines, or harness optimization spanning memory, context management, orchestration and tools.
- Rigorous scientific judgment, including when ground truth is limited, delayed or disputed.
- Strong engineering skills in Python, with production-quality code.
- Clear communication of evidence, limitations and uncertainty.
- Willingness to learn biology and drug development, and work closely with domain experts.
- Publications, research software and deployed systems are all valid evidence. Publications are welcome but not required.
Bonus
- You've built self-improving agentic systems, for example through self-play, synthetic data generation, self-training on past trajectories or test-time learning, or systems that automate ML research.
- You've built AI systems for real-world scientific workflows, such as agents that generate hypotheses and design, run and analyze experiments using lab or clinical data.
- You've built RL environments or task suites for training agents on realistic, long-horizon tasks.
- You've modeled multimodal biomedical data, such as genomics, transcriptomics, pathology and radiology images, clinical notes and EHRs, ideally combining several modalities in one model.
- You've worked on uncertainty estimation, calibration or causal inference, especially where model outputs inform high-stakes decisions.
- You've built or scaled infrastructure for efficient training and inference, such as distributed training, custom kernels (CUDA or Triton) or high-throughput serving.
- You've shipped ML systems that real users rely on, then monitored them in production and improved them from user feedback.
- You have a background in oncology, drug development or clinical research, or a track record of working closely with clinicians and biologists.
- You've worked with patient-level or clinical trial data under privacy and regulatory constraints, such as HIPAA.
Location
The preferred location for this position is in our New York City HQ, though exceptional remote candidates will also be considered.
Requirements
- Deep, hands-on expertise in mid- or post-training at scale (SFT, RL, reward modeling, or preference optimization) with direct ownership of training runs and results
- Expertise in evaluation, data and agent harness design for scientific, clinical and operational tasks
- Rigorous scientific judgment when ground truth is limited, delayed or disputed
- Strong engineering skills in Python with production-quality code
- Clear communication of evidence, limitations and uncertainty
- Willingness to learn biology and drug development and work closely with domain experts
Benefits
- Equity
Company overview
Pathos is a clinical-stage AI-driven biotechnology company focused on re-engineering drug development through advanced artificial intelligence technologies. Founded in 2022 and headquartered in Chicago, Illinois, the company leverages petabytes of real-world oncology data and patient-derived functional genomic data to identify compelling biology that traditional methods often miss. Pathos specializes in partnering with biopharmaceutical companies to develop shelved clinical-stage therapeutics by applying AI to optimize patient selection strategies, biomarker development, trial design, and clinical trial operations. The company's PathOS Platform™ is designed to accelerate the translation of real-world data into breakthrough therapies for patients with significant unmet needs, particularly in oncology. Pathos operates on the belief that cancer represents hundreds of rare diseases best described by pathways accounting for patient pathophysiology, and aims to bring precision medicines to market at an accelerated pace through strategic partnerships and AI-driven insights.